NCT05576675View on ClinicalTrials.gov

Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

4,342

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

March 31, 2022

Study Completion Date

March 31, 2022

Conditions

Gastrointestinal Surgery

Interventions

DRUG

sufentanil + nalbuphine

sufentanil 100 μ g + nalbuphine 40 mg

DRUG

Sufentanil

sufentanil 200 μ g

DRUG

hydromorphone + nalbuphine

hydromorphone 10 mg+ nalbuphine 40 mg

Trial Locations (1)

710032

YANLI, XIan

All Listed Sponsors

lead

Xijing Hospital

OTHER

NCT05576675 - Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal Surgery | Biotech Hunter | Biotech Hunter